Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep in Hemodialysis Patients
NCT00388661Phase 3Completed
- Sponsor
- Meander Medical Center
- Start
- Apr 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sleep disorder comparing Melatonin with Placebo (2 arms). Primary endpoints: Improvement of vitality (RAND SF-36) at 12 months and Improvement of general health (RAND SF-36) at 12 months. Started Apr 2007; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT00388661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388661.